$32.39
+0.120 (+0.372%)
At Close: Jun 03, 2026
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
06:30am, Thursday, 26'th Feb 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced tod
Strongly Believes that Structural Discount to Net Asset Value Due to Underperformance and Misalignment of External Manager and Common Shareholders Cannot be Repaired ADW Capital Analysis Supports Pote
Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026
06:39am, Tuesday, 24'th Feb 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
WESTPORT, Conn., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”), an owner of leading middle market businesses, today announced the appointment of Eric Weis as Presiden
Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board
04:10pm, Thursday, 19'th Feb 2026
WESTPORT, Conn., Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”), a leading “better-for-you” feminine care brand and subsidiary of Compa
Compass, Inc. (COMP) Expected to Beat Earnings Estimates: Should You Buy?
11:01am, Thursday, 19'th Feb 2026
Compass (COMP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compass Pathways Announces Pricing of $150 Million Public Offering
08:18pm, Wednesday, 18'th Feb 2026
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of i
Compass Diversified Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
04:10pm, Wednesday, 18'th Feb 2026
WESTPORT, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, ann
Compass Pathways Launches Proposed $150.0 Million Public Offering
04:06pm, Tuesday, 17'th Feb 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced tod
Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot
02:43pm, Tuesday, 17'th Feb 2026
Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot
Why Did Compass Pathways Stock Rocket Higher Today?
11:35am, Tuesday, 17'th Feb 2026
Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome.
Compass Pathways' depression treatment meets main goal in late‑stage study
06:42am, Tuesday, 17'th Feb 2026
Drug developer Compass Pathways said on Tuesday its psilocybin-based depression therapy met the main goal in a late-stage study.
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced tod
Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
08:00am, Monday, 16'th Feb 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced tha
Is Compass Stock a Buy After Barrier Capital Initiated a Position Worth Over $10 Million?
03:22pm, Sunday, 15'th Feb 2026
Barrier Capital bought 952,074 shares of Compass; estimated trade value of $10.06 million based on quarterly average pricing. Quarter-end position value increased by $10.06 million, reflecting the new
Sign In
Buy CMPGY